Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer

NCT: NCT04905069 · ACTIVE_NOT_RECRUITING

NCT IDNCT04905069
StatusACTIVE_NOT_RECRUITING
Start Date2021-12-21
Completion2030-04

Brief Summary

To demonstrate the effectiveness of the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.

Frequently Asked Questions

What is Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer?

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer is a clinical trial registered under NCT04905069. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04905069?

The current status of NCT04905069 (Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer) is: ACTIVE_NOT_RECRUITING.

When did Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer start?

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer started on 2021-12-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑